Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patients

Journal of Investigative Dermatology

Volumn 117, Issue 2, 2001, Pages 375-378

  Hoon, Dave S B ^a   Kuo, Christine T ^a   Wascher, Robert A ^a   Fournier, Pat ^b   Wang, He Jing ^c   O'Day, Steven J ^b  

^a Department of Molecular Oncology ^*  (United States)

^b JOHN WAYNE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain; Cerebrospinal fluid; Melanoma; Metastases; PCR

Indexed keywords

ANTIBODY; MELANOMA ANTIGEN 3; MONOPHENOL MONOOXYGENASE; PROTEIN; PROTEIN MART 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CELL ASSAY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DISEASE COURSE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOMA CELL; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035720234     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2001.01417.x     Document Type: Article

References (26)

1. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer
2. Cerebrospinal fluid (CSF) cytology: Current status and diagnostic applications
3. Prognostic significance of occult metastasis detected by sentinel lymphadenectomy and RT-PCR in early stage melanoma patients
4. Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor
5. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis
6. Cerebrospinal fluid cytology in patients with cancer: Mimimizing false-negative results
7. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
8. Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence
9. Cytologic characteristics of meningeal carcinomatosis: Increased diagnostic accuracy using carcinoembryonic antigen and epithelial membrane antigen immunocytochemistry
10. Assessment of messenger RNA of (1-4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma
11. Gamma knife radiosurgery for metastatic melanoma: An analysis of survival, outcome, and complications
12. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, cacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma
13. Prognostic significance of the detection of circulating malignant cells by reverse transcriptase-polymerase reaction in long-term clinically disease-free melanoma patients
14. Diagnosis and treatment of metastatic melanoma
15. Patterned distribution of metastases from malignant melanoma in humans
16. Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony stimulating factor and tamoxifen for patients with metastatic melanoma
17. Central nervous system involvement in malignant melanoma
18. Prognostic evaluation of intracranial metastasis in malignant melanoma
19. Demographics prognosis, and therapy in 702 patients with brain metastases from malignant melanoma
20. Melanoma-associated antigens as messenger RNA detection markers for melanoma
21. Surgery for metastatic melanoma
22. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis
23. Presenting features and value of diagnostic procedures in leptomeningeal metastases
24. Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
25. Management of brain metastases
26. Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients